Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1628 1655
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19531468 | COMPOSITIONS FOR TREATMENT OF GLIOMA AND USES THEREOF | Non-Final OA | Pacific Marine Biotech LLC |
| 18301487 | CLEANING COMPOSITIONS CONTAINING ALGINATE LYASE ENZYMES | Non-Final OA | The Procter & Gamble Company |
| 18820925 | PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA | Non-Final OA | Genentech, Inc. |
| 18065880 | SYNTHETIC PROTEIN CIRCUITS DETECTING SIGNAL TRANSDUCER ACTIVITY | Final Rejection | California Institute of Technology |
| 18262338 | Gut Microbiome as a Predictive Biomarker of Outcomes for Chimeric Antigen Receptor T-Cell Therapy | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17788239 | BACTERIAL CONSORTIUM COMPRISING AT LEAST ONE BACILLUS AND LACTOBACILLUS STRAIN FOR GLUTEN DEGRADATION | Non-Final OA | Evonik Operations GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy